Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
06/22/20208:01AMBusiness WireImmunoGen Presents Preclinical Data on IMGN151 at Virtual AACR Annual MeetingNASDAQ:IMGNImmunoGen Inc
06/18/20203:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/18/20203:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/18/20203:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/18/20203:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/18/20203:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/18/20207:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/04/202012:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/04/202012:08PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
06/03/20207:37AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IMGNImmunoGen Inc
06/03/20207:00AMBusiness WireImmunoGen Announces Virtual 2020 Annual Meeting of ShareholdersNASDAQ:IMGNImmunoGen Inc
06/02/20207:00AMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
06/01/20207:00AMBusiness WireImmunoGen Appoints Stacy Coen as Senior Vice President and Chief Business OfficerNASDAQ:IMGNImmunoGen Inc
05/29/20207:01AMBusiness WireImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avasti...NASDAQ:IMGNImmunoGen Inc
05/20/20203:30PMBusiness WireImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
05/14/202011:01PMBusiness WireImmunoGen to Present Preclinical Data on IMGN151 at AACR Virtual Annual MeetingNASDAQ:IMGNImmunoGen Inc
05/13/20204:01PMBusiness WireImmunoGen Announces Initial Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in ...NASDAQ:IMGNImmunoGen Inc
05/06/20203:30PMBusiness WireImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global Healthcare Virtual ConferenceNASDAQ:IMGNImmunoGen Inc
05/05/20202:19PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
05/04/20203:05PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
05/01/20205:47AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
05/01/20205:30AMBusiness WireImmunoGen Reports Recent Progress and First Quarter 2020 Financial ResultsNASDAQ:IMGNImmunoGen Inc
04/30/20203:30PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
04/28/202010:47AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IMGNImmunoGen Inc
04/28/202010:45AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IMGNImmunoGen Inc
04/17/202012:51PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IMGNImmunoGen Inc
04/16/20203:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its First Quarter 2020 Operating ResultsNASDAQ:IMGNImmunoGen Inc
04/02/20202:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/02/20206:52AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/02/20206:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN